ENDOCRINE DISRUPTORS: BISPHENOL A AND ITS RELATION WITH OBESITY
Article Sidebar
Main Article Content
Abstract
The prevalence of obesity is, worldwide, in wide intensification. This increase stimulates the search for new hypotheses that explain the genesis of the metabolic syndrome. This article seeks to clarify the obesogenic hypothesis of bisphenol A (BPA), based on its endocrine disrupting potential. Methodology: For the development of the present study, the Scopus and PubMed databases were used, from descriptors generated by the DeCS: Endocrine Disruptors; Foods; Obesity; Bisphenol A and its correspondents in English. Randomized and controlled trials were considered eligible, focusing on publications in English and Portuguese. The survey was conducted on April 11, 2017, with publications of the last five years being leaked. Based on this, 87 articles were obtained and, from the reading of the title and its abstracts, 26 publications were selected. After the complete reading of the 26 articles selected, 18 articles were obtained that served as a basis for this bibliographic review. Bisphenol A appears as an important agent that causes obesity in the contemporary world, interfering in the signaling mechanism of the endocrine system, being its high exposure linked to many of the habits present in the current context. Conclusion: Based on the possible consequences of bisphenol A, the reduction of human exposure to the compound should be considered. Based on this, alternatives to BPA in the production of industrial plastic polymers have to be considered since increased exposure to the endocrine disruptor is closely related to industrial production.
Keywords: Endocrine Disruptors, Obesity, Bisphenol A
Metrics
Article Details
This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
References
Ariemma, F. et al.(2016). Low-Dose Bisphenol-A Impairs Adipogenesis and Generates Dysfunctional 3T3-L1 Adipocytes. PLOS ONE.
Ashley-martin, J. et al. 2014. A birth cohort study to investigate the association between prenatal phthalate and bisphenol A exposures and fetal markers of metabolic dysfunction. Enviromental Health (3)1-14.
Barraza, L. A (2012) New Approach for Regulating Bisphenol A for the Protection of the Public’s Health. Journal of Law, Medicine & Ethics,9-12.
Biemann, R.; Fischer, B.; Santos, A. N. (2014) Adipogenic Effects of a Combination of the Endocrine-Disrupting Compounds Bisphenol A, Diethylhexylphthalate, and Tributyltin. Obesity Facts. 48-56.
Brasil. 2016.Vigitel Brasil: vigilância de fatores de risco e proteção para doenças crônicas por inquerito telefônico. Ministério da Saúde.
Chevalier, N.; Fenichel, P. (2015) Bisphenol A: Targeting metabolic tissues. Endocrine and Metabolic Disorders, (16) 4,299-309.
Fernandes, A. P. et al. 2013. Evaluation of a Screening System for Obesogenic. PLOS ONE, (8),10.
Furst, A. L.; Hoepker, A. C.; Francos, M. B. (2017). Quantifying Hormone Disruptors with an Engineered Bacterial Biosensor. ACS Publications, (22) 3,110-116.
Harley, K. G. et al. (2013) Prenatal and Postnatal Bisphenol A Exposure and Body Mass Index in Childhood in the CHAMACOS Cohort. Environmental Health Perspectives, (121) 4, 514-520.
Hoepner, L. A. et al. (2016) Bisphenol A and Adiposity in an Inner-City Birth Cohort. Environmental Health Perspectives, (124) 10, 1644-1650.
Khalil, N. et al. (2014). Bisphenol A and cardiometabolic risk factors in obese children. Science of the Total Environment,726-732.
LI, D.-K. et al. (2016) Urine Bisphenol-A Level in Relation to Obesity and Overweight in School-Age Children. PLOS ONE, (8) 6.
Maqbool, F. et al. (2016). Review of endocrine disorders associated with environmental toxicants and possible involved mechanisms. Life Science, 265-273.
Marmugi, A. et al. (2014) Adverse effects of long termo exposure to bisphenol A during adulthood leading to hyperglicaemia and hypercholesterolemia. Toxicology, (325)133-143.
Menale, C. et al. (2016) Bisphenol A is associated with insulin resistance and modulates adiponectin and resistin gene expression in obese children. Pediatric Obesity.
OMS. (200) Technical report series 894: Obesity: Preventing and managing the global epidemic. Organização Mundial da Saúde. 1-253.
Schneider, J. E.; Brozek, J. M.; Keen-Rhinehart, E. (2014). Our stolen figures: The interface of sexual differentiation, endocrine disruptors, maternal programming, and energy balance. Hormones and Behavior,104-119.
Vafeiadi, M. et al. (2015). Association of early life exposure to bisphenol A with obesity and cardiometabolic traits in childhood. Environmental Research, (325) 379-387.
Valentino, R. et al. (2016). Bisphenol A environmental exposure and the detrimental effects on human metabolic health: is it necessary to revise the risk assessment in vulnerable population? J Endocrinol Invest, (39) 259-263.
Vom saal, F. S. et al. (2012) . The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity. Molecular and Cellular Endocrinology, 74-84.
●